Lars Burman

5.9k total citations · 1 hit paper
120 papers, 4.6k citations indexed

About

Lars Burman is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Lars Burman has authored 120 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Epidemiology, 28 papers in Infectious Diseases and 25 papers in Molecular Biology. Recurrent topics in Lars Burman's work include Antibiotic Resistance in Bacteria (24 papers), Urinary Tract Infections Management (23 papers) and Antimicrobial Resistance in Staphylococcus (16 papers). Lars Burman is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Urinary Tract Infections Management (23 papers) and Antimicrobial Resistance in Staphylococcus (16 papers). Lars Burman collaborates with scholars based in Sweden, United States and France. Lars Burman's co-authors include Thomas Åkerlund, Christer Johansson, Kjell Tullus, Michael Norman, B. Fryklund, Sven Friberg, B. Friberg, Bo Svenungsson, Torbjörn Norén and James T. Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Applied and Environmental Microbiology.

In The Last Decade

Lars Burman

116 papers receiving 4.2k citations

Hit Papers

ACYCLOVIR VERSUS VIDARABI... 1984 2026 1998 2012 1984 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lars Burman 1.9k 1.6k 847 527 468 120 4.6k
Burke A. Cunha 1.5k 0.8× 2.1k 1.3× 803 0.9× 625 1.2× 791 1.7× 361 6.0k
Martin S. Favero 1.1k 0.6× 1.2k 0.7× 785 0.9× 251 0.5× 381 0.8× 250 4.6k
Matthew J. Arduino 2.3k 1.3× 1.9k 1.2× 1.4k 1.6× 636 1.2× 565 1.2× 162 8.1k
R. Marre 1.2k 0.7× 2.4k 1.5× 1.6k 1.9× 854 1.6× 194 0.4× 175 6.4k
W. C. Noble 3.2k 1.7× 1.4k 0.9× 1.6k 1.9× 508 1.0× 313 0.7× 222 6.3k
Stephen C. Edberg 1.6k 0.9× 1.5k 0.9× 2.5k 3.0× 343 0.7× 753 1.6× 138 8.7k
Dominique Blanc 1.9k 1.1× 1.1k 0.6× 1.6k 1.9× 784 1.5× 260 0.6× 226 5.0k
Benoît Guéry 2.1k 1.1× 2.1k 1.3× 2.0k 2.3× 734 1.4× 584 1.2× 231 6.7k
Peter Mullany 1.8k 1.0× 695 0.4× 1.7k 2.0× 1.0k 1.9× 284 0.6× 112 4.8k
C. E. Nord 1.7k 0.9× 1.3k 0.8× 1.3k 1.5× 752 1.4× 656 1.4× 182 5.3k

Countries citing papers authored by Lars Burman

Since Specialization
Citations

This map shows the geographic impact of Lars Burman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Burman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Burman more than expected).

Fields of papers citing papers by Lars Burman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Burman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Burman. The network helps show where Lars Burman may publish in the future.

Co-authorship network of co-authors of Lars Burman

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Burman. A scholar is included among the top collaborators of Lars Burman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Burman. Lars Burman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Normark, Birgitta Henriques, Birger Christensson, Andreas Sandgren, et al.. (2003). Clonal Analysis of Streptococcus pneumoniae Nonsusceptible to Penicillin at Day-Care Centers with Index Cases, in a Region with Low Incidence of Resistance: Emergence of an Invasive Type 35B Clone among Carriers. Microbial Drug Resistance. 9(4). 337–344. 36 indexed citations
2.
Lidman, Christer, Lars Burman, Å. Lagergren, & Åke Örtqvist. (2002). Limited Value of Routine Microbiological Diagnostics in Patients Hospitalized for Community-acquired Pneumonia. Scandinavian Journal of Infectious Diseases. 34(12). 873–879. 42 indexed citations
5.
Friberg, B., Lars Burman, & Sven Friberg. (1998). Zoned exponential, vertical and horizontal ultra-clean laminar airflows: No differences in bacteriological efficiency. Acta Orthopaedica Scandinavica. 69(2). 169–172. 13 indexed citations
6.
Fryklund, B., S Hæggman, & Lars Burman. (1997). Transmission of urinary bacterial strains between patients with indwelling catheters—nursing in the same room and in separate rooms compared. Journal of Hospital Infection. 36(2). 147–153. 26 indexed citations
7.
Friberg, B., Sven Friberg, & Lars Burman. (1996). Zoned vertical ultraclean operating room ventilation: A novel concept making long side walls unnecessary. Acta Orthopaedica Scandinavica. 67(6). 578–582. 20 indexed citations
8.
Fryklund, B., Kjell Tullus, & Lars Burman. (1993). Association Between Climate and Enterobacter Colonization in Swedish Neonatal Units. Infection Control and Hospital Epidemiology. 14(10). 579–582. 2 indexed citations
9.
Fryklund, B., Kjell Tullus, & Lars Burman. (1993). Relation between nursing procedures, other local characteristics and transmission of enteric bacteria in neonatal wards. Journal of Hospital Infection. 23(3). 199–210. 8 indexed citations
10.
Tullus, Kjell, Annelie Brauner, B. Fryklund, et al.. (1992). Host factors versus virulence-associated bacterial characteristics in neonatal and infantile bacteraemia and meningitis caused by Escherichia coli. Journal of Medical Microbiology. 36(3). 203–208. 22 indexed citations
11.
Nord, C. E., et al.. (1990). The significance of timing of metronidazole prophylaxis and addition of fosfomycin in colorectal surgery. An experimental study in rats.. PubMed. 156(1). 105–10. 1 indexed citations
12.
Tullus, Kjell, B. Fryklund, Birgitta Berglund, Gunilla Källenius, & Lars Burman. (1988). Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonates. Journal of Hospital Infection. 11(4). 349–356. 20 indexed citations
13.
Ferry, Sven, Lars Burman, & Bengt Mattsson. (1987). Urinary Tract Infection in Primary Health Care in Northern Sweden: II.Clinical Presentation. Scandinavian Journal of Primary Health Care. 5(3). 176–180. 9 indexed citations
14.
Ferry, Sven, Lars Burman, & Bengt Mattsson. (1987). Urinary Tract Infection in Primary Health Care in Northern Sweden: I. Epidemiology. Scandinavian Journal of Primary Health Care. 5(2). 123–128. 31 indexed citations
15.
Ferry, Sven, et al.. (1987). Short-term Nalidixic Acid Plus Sodium Citrate in Acute Lower Urinary Tract Infection. Scandinavian Journal of Infectious Diseases. 19(4). 469–477. 2 indexed citations
16.
Ferry, Sven & Lars Burman. (1987). Urinary Tract Infection in Primary Health Care in Northern Sweden: III. Bacteriology in Relation to Clinical and Epidemiological Factors. Scandinavian Journal of Primary Health Care. 5(4). 233–240. 12 indexed citations
17.
Burman, Lars. (1986). The Antimicrobial Activities of Trimethoprim and Sulfonamides. Scandinavian Journal of Infectious Diseases. 18(1). 3–13. 15 indexed citations
18.
Monsen, Tor, Stig E. Holm, & Lars Burman. (1983). A general method for cell lysis and preparation of deoxyribonucleic acid from streptococci. FEMS Microbiology Letters. 16(1). 19–24. 19 indexed citations
19.
Burman, Lars, et al.. (1983). Chemoattracting effect of human urine on motileEscherichia coli. FEMS Microbiology Letters. 20(3). 411–415. 7 indexed citations
20.
Björkstén, Bengt, Lars Burman, P. de Château, et al.. (1980). Collecting and banking human milk: to heat or not to heat?. BMJ. 281(6243). 765–769. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026